Cedar Mountain Advisors’s Guardant Health GH Stock Holding History

Cedar Mountain Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.4K	Hold	169	–	–	﹤0.01%	287
2026 Q1	$15.6K	Buy	+169	New	+$17K	﹤0.01%	357

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cedar Mountain Advisors's GH Position: Q2 2026 in Review

Cedar Mountain Advisors held its Guardant Health (GH) position steady in Q2 2026 at 169 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #287.

Cedar Mountain Advisors first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Cedar Mountain Advisors held 169 shares of Guardant Health worth $25.4K as of Q2 2026.
Cedar Mountain Advisors left its Guardant Health share count unchanged in Q2 2026.
Guardant Health made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #287 holding.
Cedar Mountain Advisors first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.